Clifford Chance with Paragon on Primed Group sale to Inflexion
Clifford Chance advised The Paragon Fund III geschlossene Investment KG (Paragon) on the sale of Primed Group to Inflexion. Primed is a provider of medical devices and sterilization services headquartered in Halberstadt, Germany. The closing of the transaction is subject to customary closing conditions.
The Clifford Chance team
The Clifford Chance team was led by partners Mark Aschenbrenner and Volkmar Bruckner and included associate Veronika Müller (all private equity, Munich), partner Torsten Syrbe and senior associate Marlene Kießling (both healthcare, Dusseldorf), partner Thomas Voland and senior associate Laura-Isabell Dietz (both regulatory, Dusseldorf), partner Dominik Engl (tax, Frankfurt), partner Christopher Fischer and associate Anna-Celine Brill (employment, Frankfurt), partner (Germany) Gerson Raiser and associate Carla Schön (compliance, Frankfurt), counsel Nicolas Hohn-Hein (IP, Dusseldorf) and partner Dimitri Slobodenjuk and counsel Arne Gayk (both antitrust, Dusseldorf) as well as partner Michal Jasek, counsel Veronika Kinclova and associate Natalie Kurkova (all corporate, Prague).
Christian Ritschka from the Austrian firm Dorda provided advice on Austrian law.
